[go: up one dir, main page]

NO20002775L - Anvendelse av ginkgo biloba ekstrakter for fremstilling av medisin - Google Patents

Anvendelse av ginkgo biloba ekstrakter for fremstilling av medisin

Info

Publication number
NO20002775L
NO20002775L NO20002775A NO20002775A NO20002775L NO 20002775 L NO20002775 L NO 20002775L NO 20002775 A NO20002775 A NO 20002775A NO 20002775 A NO20002775 A NO 20002775A NO 20002775 L NO20002775 L NO 20002775L
Authority
NO
Norway
Prior art keywords
ginkgo biloba
medicine
preparation
biloba extracts
extracts
Prior art date
Application number
NO20002775A
Other languages
English (en)
Other versions
NO323707B1 (no
NO20002775D0 (no
Inventor
Katy Drieu
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of NO20002775D0 publication Critical patent/NO20002775D0/no
Publication of NO20002775L publication Critical patent/NO20002775L/no
Publication of NO323707B1 publication Critical patent/NO323707B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Addiction (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Anesthesiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO20002775A 1997-12-03 2000-05-30 Anvendelse av Ginkgo biloba ekstrakter for fremstilling av et medikament. NO323707B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9715230A FR2771639B1 (fr) 1997-12-03 1997-12-03 Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a faciliter le sevrage d'individus dependants de la consommation d'une substance engendrant une dependance et/ou une addiction
PCT/FR1998/002576 WO1999027943A1 (fr) 1997-12-03 1998-12-01 Utilisation d'extraits de ginkgo biloba pour preparer un medicament

Publications (3)

Publication Number Publication Date
NO20002775D0 NO20002775D0 (no) 2000-05-30
NO20002775L true NO20002775L (no) 2000-06-02
NO323707B1 NO323707B1 (no) 2007-06-25

Family

ID=9514108

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002775A NO323707B1 (no) 1997-12-03 2000-05-30 Anvendelse av Ginkgo biloba ekstrakter for fremstilling av et medikament.

Country Status (21)

Country Link
US (2) US6936285B1 (no)
EP (1) EP1035858B1 (no)
JP (1) JP2001524528A (no)
KR (1) KR100597139B1 (no)
CN (1) CN1188141C (no)
AT (1) ATE216587T1 (no)
AU (1) AU749752B2 (no)
CA (1) CA2312856C (no)
CZ (1) CZ299427B6 (no)
DE (1) DE69805096T2 (no)
DK (1) DK1035858T3 (no)
ES (1) ES2177097T3 (no)
FR (1) FR2771639B1 (no)
HU (1) HUP0100223A3 (no)
IL (1) IL136304A0 (no)
NO (1) NO323707B1 (no)
NZ (1) NZ505516A (no)
PL (1) PL190849B1 (no)
PT (1) PT1035858E (no)
RU (1) RU2207140C2 (no)
WO (1) WO1999027943A1 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2827518B1 (fr) * 2001-07-17 2005-07-08 Sod Conseils Rech Applic Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a traiter la sarcopenie
KR20030080623A (ko) * 2002-04-09 2003-10-17 주식회사 바이오메딕스 금연을 돕는 조성물 및 제조방법
US7169704B2 (en) 2002-06-21 2007-01-30 Samsung Electronics Co., Ltd. Method of cleaning a surface of a water in connection with forming a barrier layer of a semiconductor device
JPWO2005066357A1 (ja) * 2004-01-05 2007-12-20 三菱ウェルファーマ株式会社 精神疾患関連分子のスクリーニング方法
US20090099102A1 (en) * 2005-10-27 2009-04-16 The Brigham And Women's Hospital, Inc. Ginkgolides in the Treatment and Prevention of Ovarian Cancer
DE102005062417A1 (de) * 2005-12-27 2007-08-23 Korth, Ruth-Maria, Dr.med. Kompositionen mit spezifischen und unspezifischen Lipidantagonisten
US11039997B2 (en) 2005-12-27 2021-06-22 Ruth-Maria Korth Cosmetic, dermatic, protective compositions comprising phospholipids, lecithins with peptides and at least one acetylating compound
RU2406488C1 (ru) * 2009-04-20 2010-12-20 Учреждение Российской академии медицинских наук Научно-исследовательский институт фармакологии Сибирского отделения РАМН Нейропротекторное средство
EP2459205A1 (en) * 2009-07-28 2012-06-06 Velleja Research SRL Ginkgo biloba extract with a standardised ginkgo flavone glycosides content deprived of the paf-antagonist terpenic fraction, and compositions containing it, for the prevention and treatment of circulatory, cognitive, geriatric and sensory disorders
CN101946784B (zh) * 2010-09-26 2013-04-03 云南省农业科学院生物技术与种质资源研究所 银杏内酯b在制备抗烟草花叶病毒药物中的应用
CN112089772B (zh) * 2020-09-15 2022-02-18 汉济生物科技（武汉）有限公司 一种药物组合物及其在制备戒毒药物中的应用
CN113144021B (zh) * 2021-05-21 2022-08-19 常州工业职业技术学院 一种戒毒用中药组合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8725871D0 (en) * 1987-11-04 1987-12-09 Scras Ginkgolide derivatives
DE3940092A1 (de) * 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
DE3940094A1 (de) * 1989-12-04 1991-06-06 Montana Ltd Wirkstoffkonzentrate und neue wirkstoff-kombinationen aus blaettern von ginkgo biloba, ein verfahren zu ihrer herstellung und die wirkstoff-konzentrate bzw. die wirkstoff-kombinationen enthaltenden arzneimittel
DE3940091A1 (de) * 1989-12-04 1991-06-06 Schwabe Willmar Gmbh & Co Extrakt aus blaettern von ginkgo biloba, verfahren zu seiner herstellung und den extrakt enthaltende arzneimittel
DE4008046C2 (de) * 1990-03-14 1999-09-16 Irbit Research & Consulting Ag Verfahren zur Herstellung eines Formteils aus Melaminharzschaumstoff
JP2924099B2 (ja) * 1990-06-13 1999-07-26 茂 川瀬 経口節煙剤
JP3188461B2 (ja) * 1991-12-23 2001-07-16 ドクター・ビィルマール・シュバーベ・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング・ウント・カンパニー 緊張及び不安の処置のためのビロバリドを含有する医薬製剤
JP3181356B2 (ja) * 1992-03-25 2001-07-03 ダイセル化学工業株式会社 中枢神経作用薬
DE4317868C2 (de) * 1993-05-28 1996-04-18 Arrowdean Ltd Neuartiges Anxiolytikum
JPH0753371A (ja) * 1993-08-11 1995-02-28 Daicel Chem Ind Ltd 抗痙攣薬
KR0136986B1 (ko) * 1993-12-31 1998-04-25 김준웅 신규 징코라이드 유도체와 이의 제조방법
AUPM835394A0 (en) * 1994-09-23 1994-10-13 King, Michael G. Dr. Method for controlling or eliminating the need to smoke tobacco, and for treating ailments which may lead to the said need
US5976548A (en) * 1994-11-08 1999-11-02 Viva America Marketing, Inc. Nutritional supplement composition and use
GB9508533D0 (en) * 1995-04-27 1995-06-14 Sod Conseils Rech Applic Flavonoid extract of ginkgo biloba as flavouring and/or texturing agent

Also Published As

Publication number Publication date
CA2312856A1 (fr) 1999-06-10
WO1999027943A1 (fr) 1999-06-10
HUP0100223A2 (hu) 2001-10-28
CN1280499A (zh) 2001-01-17
EP1035858B1 (fr) 2002-04-24
NO323707B1 (no) 2007-06-25
IL136304A0 (en) 2001-05-20
HUP0100223A3 (en) 2004-05-28
AU749752B2 (en) 2002-07-04
FR2771639B1 (fr) 2000-05-05
US6936285B1 (en) 2005-08-30
US20040180105A1 (en) 2004-09-16
CZ20002007A3 (cs) 2000-11-15
ATE216587T1 (de) 2002-05-15
PL340794A1 (en) 2001-02-26
PT1035858E (pt) 2002-10-31
DE69805096T2 (de) 2002-11-14
KR20010032716A (ko) 2001-04-25
NZ505516A (en) 2001-10-26
JP2001524528A (ja) 2001-12-04
PL190849B1 (pl) 2006-02-28
CZ299427B6 (cs) 2008-07-23
ES2177097T3 (es) 2002-12-01
NO20002775D0 (no) 2000-05-30
AU1438099A (en) 1999-06-16
DK1035858T3 (da) 2002-08-19
EP1035858A1 (fr) 2000-09-20
CN1188141C (zh) 2005-02-09
DE69805096D1 (de) 2002-05-29
KR100597139B1 (ko) 2006-07-06
CA2312856C (fr) 2009-04-07
RU2207140C2 (ru) 2003-06-27
FR2771639A1 (fr) 1999-06-04

Similar Documents

Publication Publication Date Title
DE69811378D1 (de) Zusammensetzungen zur behandlung von nikotinabhängigkeit, enthaltend mecamylamin und bupropion
NO20002775L (no) Anvendelse av ginkgo biloba ekstrakter for fremstilling av medisin
EE04175B1 (et) Meetod topiramaadi farmatseutilise kompositsioonivalmistamiseks, farmatseutiline kompositsioon ning topiramaadi kasutamine diabeedi raviks ette nähtud ravimi valmistamiseks
ES2172239T3 (es) Sistema osmotico de liberacion de farmacos.
DE69607015D1 (de) Inhalationsvorrichtung zur genauen und reproduzierbaren, datierten abgabe von pulverförmigen arzneistoffen
BG104317A (en) Method for the treatment of capsules and dry, powder pharmaceutical forms
DE69820108D1 (de) Doppelkapsel zur verabreichung von arzneimitteln für vielfache therapien
BG103552A (bg) Терапевтични средства
DE60131760D1 (de) Vorrichtung zur verabreichung von physiologisch aktiven wirkstoffen in pulverform
ATE360427T1 (de) Pharmazeutische und/oder kosmetische zusammensetzung zur behandlung von lokaler adipositas und zellulitis
NO20010627D0 (no) Anvendelse av Gingko Biloba ekstrakter for fremstilling av et medikament for behandling av amyotrofisk lateral sclerose
ES2177324T3 (es) Preparaciones de insulina destinadas a la entrega pulmonar y que contiene mentol.
NO305948B1 (no) Basisk substituerte benzolguanidiner, deres anvendelse til fremstilling av medikament eller diagnostikum samt medikament inneholdende forbindelsen
ID27023A (id) Turunan imidazola bersubstitusi bifenilsulfonil, proses penyiapannya, penggunaannya sebagai obat atau zat diagnosa dan obat yang mengandungnya
DE60007074D1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
DE69823226D1 (de) Pharmazeutische zusammmensetzung, enthaltend ticlopidin und ginkgo biloba extrakt
NO306993B1 (no) Piperidinylmetyloksyzolidin-2-on-derivater, farmasoeytiske preparater som inneholder slike, samt anvendelse av forbindelsene til fremstilling av legemidler
NO305795B1 (no) Substituerte benzensulfonylurinstoffer og -tiourinstoffer, og anvendelse i farmas°ytiske preparater pÕ basis av disse forbindelsene samt legemidler inneholdende forbindelsene
NO975155D0 (no) Anvendelse av forskolin eller ekstakter inneholdende denne ved fremstilling av et medikament for behandling av alkoholavhengighet
ATE230998T1 (de) Arzneimittel zur manipulation der t-zell immunantwort
Hammond Resolution in dissolution. The regulatory environment facing dissolution, and where you can get help
BR0211734A (pt) Derivados do ácido 5,6,6a,11b-tetraidro- 7-oxa-5-aza- benzo [c] fluoreno-6-carboxìlico substituìdos como antagonistas do nmda
Leone The Pharmacy and Drugs Act, 1988 (No. 1 of 1988), 3 March 1988
HUP9902469A3 (en) Use of ginkgo biloba extracts for the preparation of pharmaceutical compositions, and method of cosmetic treatment using a ginkgo biloba extract
UA39141C2 (uk) Засіб "кратал" для лікування захворювань серцево- судинної системи

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees